The Medicinal Chemicals and Botanical Products industry on FinBizNet covers 86 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 86 |
|---|---|
| Combined market cap | ₹17,48,316 Cr |
| Median P/E (profitable companies) | 30.0 |
| Median return on equity | 10.2% |
| Companies with latest quarterly results | 65 of 86 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.7% | ₹16,199 Cr | ₹1,995 Cr | Q2 FY27 |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.7% | ₹2,206 Cr | ₹436 Cr | Q2 FY27 |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.3% | ₹7,910 Cr | ₹928 Cr | Q2 FY27 |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.5% | ₹8,698 Cr | ₹913 Cr | Q2 FY27 |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.7% | ₹7,404 Cr | ₹852 Cr | Q2 FY27 |
| Mankind Pharma | ₹1,09,870 Cr | 57.0 | 12.4% | ₹4,338 Cr | ₹716 Cr | Q2 FY27 |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30.0 | 9.9% | ₹10,263 Cr | ₹1,124 Cr | Q2 FY27 |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.9% | ₹7,827 Cr | ₹1,155 Cr | Q2 FY27 |
| Glenmark Pharmaceuticals Limited | ₹75,556 Cr | 55.1 | 14.1% | ₹4,157 Cr | ₹264 Cr | Q2 FY27 |
| Alkem Laboratories Ltd | ₹65,139 Cr | 27.5 | 17.6% | ₹4,552 Cr | ₹667 Cr | Q2 FY27 |
| Gland Pharma Limited | ₹53,843 Cr | 53.1 | 10.5% | ₹1,834 Cr | ₹291 Cr | Q2 FY27 |
| Ipca Laboratories Ltd. | ₹49,178 Cr | 42.4 | 13.2% | ₹2,910 Cr | ₹389 Cr | Q2 FY27 |
| Wockhardt Ltd | ₹33,061 Cr | 157.4 | 4.0% | ₹969 Cr | ₹73 Cr | Q2 FY27 |
| Acutaas Chemicals Ltd | ₹32,068 Cr | 92.2 | 23.5% | ₹437 Cr | ₹123 Cr | Q2 FY27 |
| Neuland Laboratories Ltd. | ₹26,836 Cr | 73.6 | 21.4% | ₹450 Cr | ₹52 Cr | Q2 FY27 |
| Granules India Ltd | ₹20,836 Cr | 34.3 | 13.5% | ₹1,560 Cr | ₹182 Cr | Q2 FY27 |
| Shilpa Medicare Ltd. | ₹19,312 Cr | 80.4 | 9.8% | ₹529 Cr | ₹79 Cr | Q2 FY27 |
| Natco Pharma Ltd | ₹15,869 Cr | 10.2 | 16.9% | ₹967 Cr | ₹203 Cr | Q2 FY27 |
| Symbiotec Pharmalab | ₹9,886 Cr | 86.5 | — | ₹280 Cr | ₹52 Cr | Q2 FY27 |
| Procter & Gamble Health Ltd | ₹9,638 Cr | 29.3 | 61.6% | ₹382 Cr | ₹112 Cr | Q2 FY27 |
| Fdc Ltd. | ₹6,358 Cr | 22.6 | 11.8% | ₹572 Cr | ₹49 Cr | Q2 FY27 |
| Iol Chemicals & Pharmaceuticals Ltd. | ₹6,016 Cr | 43.9 | 7.9% | ₹795 Cr | ₹65 Cr | Q2 FY27 |
| Morepen Laboratories Ltd. | ₹5,206 Cr | 55.1 | 7.8% | ₹747 Cr | ₹89 Cr | Q2 FY27 |
| Orchid Pharma Ltd | ₹5,190 Cr | 517.5 | 0.7% | ₹341 Cr | ₹29 Cr | Q2 FY27 |
| Supriya Lifescience Limited | ₹5,134 Cr | 24.7 | 19.1% | ₹206 Cr | ₹29 Cr | Q2 FY27 |
| Gujarat Themis Biosyn Ltd. | ₹5,051 Cr | 90.8 | 17.4% | ₹50 Cr | ₹-14 Cr | Q2 FY27 |
| Gufic Biosciences Ltd. | ₹4,871 Cr | 76.4 | 10.1% | ₹288 Cr | ₹23 Cr | Q2 FY27 |
| Aarti Drugs Ltd. | ₹4,650 Cr | 23.9 | 13.4% | ₹826 Cr | ₹83 Cr | Q2 FY27 |
| Jeena Sikho Lifecare Ltd | ₹4,506 Cr | 20.6 | 59.9% | ₹235 Cr | ₹37 Cr | Q2 FY27 |
| Rpg Life Sciences Ltd. | ₹4,310 Cr | 37.5 | 20.3% | ₹212 Cr | ₹28 Cr | Q2 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL). Showing the 30 largest of 86 companies.
Kwality Pharmaceuticals Ltd · Unichem Laboratories Ltd. · Ind-Swift Laboratories Ltd. · Hikal Ltd. · Fredun Pharmaceuticals Ltd · Indoco Remedies Ltd. · Venus Remedies Ltd. · Ngl Fine-Chem Ltd. · Beta Drugs Ltd · Accent Microcell Limited · ANLON HEALTHCARE LIMITED · Kopran Ltd. · Fermenta Biotech Ltd · Bharat Parenterals Ltd · Bajaj Healthcare Ltd · Sigachi Industries Limited · Vikram Thermo (India) Ltd. · Themis Medicare Ltd. · Anuh Pharma Ltd. · Shree Ganesh Remedies Ltd · Zim Laboratories Ltd · Kilitch Drugs India Ltd · Aarey Drugs & Pharmaceuticals Ltd. · Lyka Labs Ltd. · Nectar Lifesciences Ltd · Smruthi Organics Ltd · Coral Laboratories Ltd. · Syschem (India) Ltd. · Kimia Biosciences Ltd · Par Drugs And Chemicals Limited · Auro Laboratories Ltd. · Bal Pharma Ltd. · Panchsheel Organics Ltd. · Lactose (India) Ltd. · Krebs Biochemicals & Industries · Parnax Lab Ltd. · Godavari Drugs Ltd. · Tyche Industries Ltd. · Vaishali Pharma Ltd · Mercury Laboratories Ltd · Sunil Healthcare Ltd · Vineet Laboratories Ltd · Biofil Chemicals & Pharmaceuticals Ltd. · Ang Lifesciences India Ltd · Mangalam Drugs & Organics Ltdte · Vasundhara Rasayans Ltd · Ishita Drugs & Industries Ltd. · Colinz Laboratories Ltd · Ortin Laboratories Ltd · Remedium Lifecare Ltd · Kobo Biotech Ltd · Decipher Labs Ltd · Desh Rakshak Aushdhalaya Ltd. · Hemo Organic Limited · J.B.Chemicals & Pharmaceuticals Ltd. · Parmax Pharma Ltd
FinBizNet tracks 86 listed companies in the Medicinal Chemicals and Botanical Products industry, including Sun Pharmaceutical Industries Limited, Laurus Labs Ltd, Zydus Lifesciences Ltd, Dr.Reddys Lab, Cipla Limited, Mankind Pharma, Aurobindo Pharma Ltd., Lupin Ltd, among others.
By market capitalisation, the largest Medicinal Chemicals and Botanical Products companies are Sun Pharmaceutical Industries Limited (₹4,56,425 Cr), Laurus Labs Ltd (₹1,31,242 Cr), Zydus Lifesciences Ltd (₹1,19,651 Cr), Dr.Reddys Lab (₹1,15,464 Cr), Cipla Limited (₹1,14,712 Cr).
The 86 Medicinal Chemicals and Botanical Products companies tracked on FinBizNet have a combined market capitalisation of about ₹17,48,316 Cr.
The median price-to-earnings ratio across 71 profitable Medicinal Chemicals and Botanical Products companies is 30.0, and the median return on equity across the industry is 10.2%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Medicinal Chemicals and Botanical Products industry.